IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 306 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $9,970 | +6.5% | 209,194 | -3.1% | 0.07% | -4.2% |
| Q1 2024 | $9,359 | +687.8% | 215,893 | +819.3% | 0.07% | +787.5% |
| Q4 2023 | $1,188 | -87.5% | 23,484 | -91.1% | 0.01% | -89.9% |
| Q1 2023 | $9,483 | -17.5% | 265,330 | -12.8% | 0.08% | -52.7% |
| Q4 2022 | $11,497 | -96.0% | 304,390 | +4643.5% | 0.17% | +4075.0% |
| Q3 2022 | $284,000 | -79.6% | 6,417 | -82.9% | 0.00% | -76.5% |
| Q2 2022 | $1,392,000 | +131.2% | 37,590 | +90.0% | 0.02% | +183.3% |
| Q4 2021 | $602,000 | +119.7% | 19,788 | +142.1% | 0.01% | +50.0% |
| Q3 2021 | $274,000 | -78.2% | 8,173 | -69.2% | 0.00% | -84.0% |
| Q3 2020 | $1,258,000 | +347.7% | 26,507 | +346.7% | 0.02% | +66.7% |
| Q1 2020 | $281,000 | 0.0% | 5,934 | +27.5% | 0.02% | +200.0% |
| Q4 2019 | $281,000 | -94.6% | 4,654 | -92.7% | 0.01% | -98.7% |
| Q1 2019 | $5,156,000 | +1636.0% | 63,522 | +1054.9% | 0.38% | +1728.6% |
| Q4 2018 | $297,000 | – | 5,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,347,926 | $313,529,000 | 3.18% |
| Sicart Associates LLC | 291,254 | $9,769,000 | 2.66% |
| Camber Capital Management LP | 2,500,000 | $83,850,000 | 2.58% |
| SECTOR GAMMA AS | 263,870 | $8,850,000 | 1.76% |
| Parkman Healthcare Partners LLC | 136,380 | $4,574,000 | 1.16% |
| Eversept Partners, LP | 450,501 | $15,109,804 | 1.05% |
| SPHERA FUNDS MANAGEMENT LTD. | 350,000 | $11,739,000 | 0.99% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $559,000 | 0.80% |
| Sonora Investment Management, LLC | 163,703 | $5,491,000 | 0.69% |
| ARK Investment Management | 8,511,384 | $285,472,000 | 0.69% |